During the 1970s and 1980s, a number of factors emerged that were associated with the risk of breast cancer. The majority of these were not modifiable factors and, although much had been learned about breast cancer risk, this information could not be easily translated into recommendations to women for lowering their breast cancer risk. These factors were considered in developing the hypothesis that physical activity would be associated with breast cancer risk, with women who participated consistently in exercise activity having lower risk than inactive women. Since the mid-1990s a large series of case-control studies and cohort studies have confirmed that physical activity is a modifiable risk factor for breast cancer. Further, when physical activity is a persistent lifestyle practice, reductions in risk are quite clear, with vigorous activities possibly more protective against breast cancer than moderate forms of activity. Thus, maintaining a physically active lifestyle, which has broad health benefits, additionally has the potential to lower breast cancer risk.
Introduction
The ultimate goal for an epidemiologist is to understand the etiology of a disease, and then develop approaches for disease prevention that use a broad public health paradigm and are applicable to large segments of the population at risk. Thus, epidemiology contrasts with laboratory sciences in its focus on developing population-level recommendations for risk reduction. In this review, our progress in understanding breast cancer risk provides a clear example of the evolution of new hypotheses in epidemiology, their assessment in analytical epidemiological studies (that is, case-control studies and cohort studies) and the potential for a population-based approach to lower breast cancer risk.
What is common among acknowledged breast cancer risk factors?
The most consistently acknowledged risk factors for breast cancer other than gender and race/ethnicity are age, family history of breast cancer, early menarche, late age at first birth, nulliparity, late age at menopause, high postmenopausal weight or substantial weight gain as an adult, exposure to high levels of ionizing radiation and a history of benign proliferative breast disease (MacMahon et al., 1970; Kelsey and Gammon, 1990; Hunter and Willett, 1993; Kelsey et al., 1993) . The descriptive epidemiology of breast cancer, as well as the variation in incidence rates by age, gender, race/ ethnicity and time, has provided a number of hints that led investigators to study these risk factors. The age-incidence relationship shows a rapid increase in breast cancer incidence during a woman's reproductive years; this slope decreases substantially around age 50 years to reflect a more gradual increase in incidence or a even a flattening of incidence rates at older ages. This pattern of incidence rates by age is relatively constant across different populations. Observations made on the age-incidence relationships provided the initial suggestions that reproductive factors would be important determinants of breast cancer risk. In fact, early menarche, late childbirth or nulliparity, and older age at menopause have proven to be highly reproducible risk factors over time. These risk factors implicate the ovarian hormones, estradiol and progesterone, in the etiology of breast cancer . These hormones influence normal breast cell growth and development. Endogenous estrogens and progesterone, as well as exogenous formulations of these hormones, promote cellular proliferation in the breast, providing greater opportunity for the accumulation of random errors, which may lead to tumor development (Henderson and Feigelson, 2000) .
Other breast cancer risk factors can be understood in light of their potential effects on a woman's cumulative exposure to these ovarian hormones. High body mass index after menopause provides an example. As a woman transitions through menopause, her ovaries gradually shut down their hormone production (with the exception of testosterone), thus eliminating the major source of circulating estradiol. However, body fat contains an enzyme, aromatase, that metabolizes an adrenal androgen, androstenedione, into estrone; further metabolism leads to the conversion of estrone to estradiol (Baglietto et al., 2009) . Hence, heavy women will have higher levels of estradiol after menopause than normal weight and thin women. These higher circulating levels of estradiol are measurable in blood after approximately 6 years have elapsed since menopause (Baglietto et al., 2009) . Heavier women also have lower levels of sex-hormone-binding globulin (SHBG), a protein that binds a high proportion of estradiol and testosterone; binding of estradiol to SHBG essentially inactivates this hormone (Grodin et al., 1973; Anderson, 1974) . Thus, the decrease in SHBG also leads to greater exposure to estradiol among heavy women, leading to a proportionally greater increase in breast cancer risk (Endogenous Hormones and Breast Cancer Collaborative Group, 2003) . Menopausal hormone therapy also increases the risk of breast cancer, particularly when estrogen is combined with a progestin (Lee et al., 2005) . Alcohol is another potential risk factor for breast cancer, possibly acting to increase the risk by increasing certain estrogen metabolites (Singletary and Gapstur, 2001 ).
Well-designed seroepidemiological studies comparing the hormone levels of women at high and low risk of breast cancer as well as studies comparing the hormone levels of breast cancer patients and controls have shown that differences in estrogen levels may account for differences in breast cancer risk (Bernstein and Ross, 1993) . In a series of studies conducted in the 1980s, we suggested that pregnancy permanently lowers the levels of estradiol and prolactin among premenopausal women (Bernstein et al., 1985) , and that women in Asia have lower estrogen levels than US white women, premenopausally (Bernstein et al., 1990b) and postmenopausally (Shimizu et al., 1990) . We conducted case-control studies to compare women with a history of localized breast cancer who received minimal treatment with healthy control women and showed that the breast cancer patients have higher circulating estrogen levels than the controls (Bernstein et al., 1990a, b) . Results from such case-control studies could be biased because the blood samples were collected after patients' diagnoses. Cohort studies, however, collect samples before the development of disease. In a large collaboration, data were combined from nine prospective cohort studies of postmenopausal women which had assessed the relationship between endogenous hormones and breast cancer risk; the results of this pooled analysis showed that breast cancer risk of postmenopausal women increased with increasing estradiol levels (Endogenous Hormones and Breast Cancer Collaborative Group, 2002). Each of these cohort studies collected blood samples from women with no cancer diagnosis and then followed women over time for the development of breast cancer. Women in the top quintile of estradiol had more than twice the risk of breast cancer as women in the lowest estradiol quintile.
Developing the basis for focusing on physical activity
With this strong evidence that ovarian hormones have a key role in the etiology of breast cancer, we sought factors that had not already been studied but could alter endogenous hormone patterns and therefore lower breast cancer risk. The known reproductive risk factors (menarche, menopause, pregnancy history) were not readily modifiable. Studies had suggested that strenuous physical activity could delay menarche or cause secondary amenorrhea (Frisch et al., 1981) or oligomenorrhea among elite women athletes (Schwartz et al., 1981; Shangold and Levine, 1982; Shangold, 1985) . Three of four studies that compared the prevalence of anovulation in female athletes and sedentary women found that anovulation was far more frequent among the athletes (Dale et al., 1979; Broocks et al., 1990; Pirke et al., 1990; Prior et al., 1990) . Using data from these studies, one can construct a summary odds ratio (OR, adjusted for between study differences) for the risk of anovulatory menstrual cycles among athletes compared to more sedentary women. The results of this assessment indicate a sixfold increased risk of anovulatory menstrual cycles among the athletes (OR ¼ 5.9, P ¼ 0.0006).
Moderate physical activity during adolescence also can lead to anovulatory menstrual cycles. In a study of high-school girls, those who engaged in regular, moderate physical activity (averaging at least 600 kcal of energy expended per week over the school year) were 2.9 times more likely to experience anovulatory cycles than girls who engaged in lesser amounts of physical activity (Bernstein et al., 1987) . Two studies of the relationship between exercise activity and serum estradiol levels during ovulatory menstrual cycles showed that athletes had substantially lower estradiol levels over the menstrual cycle than did sedentary women (Russell et al., 1984; Broocks et al., 1990) .
One can develop a model to explain the influence of exercise activity on menstrual function among premenopausal women. This model suggests a continuum of changes in menstrual cycles with greater disruption of menstrual function as the intensity and duration of exercise activity increase (Figure 1 ). On the basis of such convincing evidence that exercise alters menstrual function and cumulative exposure to ovulatory menstrual cycles, we suggested that it would reduce breast cancer risk (Bernstein et al., 1992) .
Physical activity and breast cancer risk
In 1994, we reported the first results of a study designed specifically to assess the association between recrea- Approaches to lower breast cancer risk L Bernstein
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tional physical activity and breast cancer risk (Bernstein et al., 1994) . Considering that physical activity has considerable impact on menstrual cycle function during adolescence (Bernstein et al., 1987) , this case-control study of women aged 40 years or younger collected extensive histories of all exercise activities in which a woman participated over her lifetime, providing detail on activity during every year of the women's lives from menarche onward. These data were used to assess breast cancer risk associated with average hours per week of physical activity during the 10 years following menarche, and average hours per week of physical activity from menarche through 1 year before diagnosis ('lifetime activity') for newly diagnosed patients (cases) or a comparable age for unaffected women (controls). Although activity during adolescence was strongly protective against breast cancer, lifetime average hour per week of physical activity was more clearly associated with risk. Among women who exercised at least 3.8 h per week over their lifetimes (mean age, 36 years), risk was reduced by 58% relative to inactive women (OR, 0.42; 95% confidence interval (CI), 0.27-0.64); risk declined as the average hours of physical activity increased (P-value, linear trend, 0.0001) (Bernstein et al., 1994) . To address the issue of whether postmenopausal women would also benefit from physical activity, we conducted a large case-control study of breast cancer among postmenopausal women aged 55 years or older (Carpenter et al., 1999 (Carpenter et al., , 2003 . This study also showed an inverse relationship between breast cancer and lifetime history of exercise activity and found measures of lifetime activity to be stronger risk predictors than recent activity (that is, that performed in the 10 years before study participation or breast cancer diagnosis). Following these studies, we conducted two additional case-control studies expanding our findings to black women and white women aged 35-64 years who participated in the Women's Contraceptive and Reproductive Experiences study (Bernstein et al., 2005) , and to Asian-American women (Yang et al., 2003) . Both studies showed reductions in risk for women who exercised consistently throughout their lives. Most recently, in the California Teachers Study, a cohort study in which we have followed more than 130 000 female public school professionals since 1995, long-term strenuous physical activity (that is, from high school through 54 years of age), but not recent physical activity (that is, that in the 3 years before joining the cohort), was associated with decreased risk for both invasive breast cancer and in situ breast cancer (Dallal et al., 2007) . The results showing a reduction in risk for in situ breast cancer among exercising women confirmed our earlier case-control study of in situ breast cancer (Patel et al., 2003b) . In the California Teachers Study, risk of invasive breast cancer declined with increasing long-term activity among estrogen receptor (ER)-negative breast cancer, whereas long-term activity did not strongly affect ER-positive breast cancer. In two of our previous studies (Bernstein et al., 1994; Carpenter et al., 2003) , we had evaluated whether the impact of physical activity varied by ER status. Although the impact appeared somewhat greater for ER-negative tumors, it did not differ statistically by ER status (Enger et al., 2000) .
In 2001, the International Agency for Research on Cancer convened a committee to assess the relationship between cancer and two modifiable cancer risk factors, inactivity and obesity, and to determine the strength of the evidence by cancer site (Vainio and Bianchini, 2000) . For breast cancer, the committee comprehensively reviewed all studies published to date and judged the evidence to be convincing with physically active women experiencing approximately a 20-40% lower breast cancer risk than inactive women. No formal meta-analysis was performed. The report suggested that substantial activity is required for a reduction in breast cancer risk to be measurable, on the order of 30-60 min a day of moderate to vigorous intensity physical activity (Vainio and Bianchini, 2000) .
More recently, Monninkhof et al. (2007) conducted a systematic review of 19 cohort studies and 29 casecontrol studies published between 1994 and early 2006, concluding that evidence that physical activity reduces breast cancer risk among postmenopausal women was strong with risk reductions ranging from 20 to 80%; evidence for premenopausal women was considered to be weaker. This 20-80% reduction is rather vague in that it represents the risk reductions in a variety of studies that have made comparisons between vastly different levels of physical activity exposure. More meaningful is the estimate provided in this publication suggesting that for each additional hour per week of physical activity, a woman's risk of breast cancer is reduced by 6% (95% CI, 3-8%). Clearly, we believe that measures of lifetime, or long-term physical activity provide the best means for assessing the relationship between physical activity and breast cancer risk. Few other case-control studies have collected lifetime histories of physical activity (Friedenreich, 2001 ).
Since Monninkhof et al. (2007) published their review, several large and important cohort studies have published results on the association of physical activity with breast cancer risk. Leitzman et al. (2008) used the large, prospective National Institutes of Health-American Association of Retired Persons Diet and Health Study to examine the association between physical activity and postmenopausal breast cancer overall and by tumor steroid receptor status. With physical activity measured during the year before cohort formation, these investigators showed that, overall, the most active women (active at least five times a week) had 13% lower breast cancer risk than inactive women, with the reduction in risk stronger for women with ER-negative breast cancer than for women with ER-positive tumors, confirming results from the California Teachers Study cohort (Dallal et al., 2007) . The Breast Cancer Detection Demonstration Project Follow-up Study used baseline information on recreational, household and occupational activities to assess the risk of postmenopausal breast cancer among 1506 cases diagnosed during 12 years of follow-up (Leitzman et al., 2008) ; the authors reported a modest 13% reduction in risk among women who engaged in the most vigorous activities relative to inactive women. This reduction in risk was restricted to lean women (body mass index, o25.0 kg/m 2 ; relative risk, 0.68; 95% CI, 0.54-0.85). Unlike the two previously mentioned cohorts (Dallal et al., 2007; Leitzman et al., 2008) , these results did not vary by receptor subtype of the tumor. Analysis of the US Radiologic Technologists cohort also confirms reductions in risk among physically active women, showing that those who walked or hiked at least 10 h per week had the greatest reductions in risk compared with those not participating in these activities (Howard et al., 2009) . Importantly, the association for postmenopausal women was modified by hormone therapy with risk reductions restricted to women who had never used hormone therapy, a finding that has been previously reported (Patel et al., 2003a) . In the current era, with the declining use of hormone therapy, and substantially increased rates of obesity, physical inactivity is likely to increase in importance as a breast cancer risk factor.
What can we recommend to women?
Several issues remain, before we can provide an exact prescription to women on how and when to exercise to lower their breast cancer risk. For example, owing to the observational methods used in epidemiological studies, we cannot identify which exercise approaches are best to use to lower a woman's risk of breast cancer. In addition, we do not know at what age activity proves to be most beneficial. An analysis of the Nurses Health Study II, restricted to premenopausal women, provides some insight into the question of whether physical activity at particular ages has a greater influence on breast cancer risk than activity at other ages (Maruti et al., 2008) . In this cohort study of 64 777 women who documented their leisure-time activity from age 12 years through their age in 1997, 550 women developed breast cancer during the 6-year follow-up period. The most active women (those whose activity was equivalent to 3.25 h per week of running or 13 h per week of walking) had 23% lower risk of breast cancer than the least active women. With correction for measurement error the risk reduction increased to 39%. When these investigators compared activity during youth (ages 12-22 years) with that performed during adulthood (ages 23 years or older), activity during youth had a greater impact on breast cancer risk, and it did not seem to matter whether the woman continued physical activity in her adult years. These results did not differ by ER status. This study confirmed the marked protective effect of physical activity overall, and of physical activity during adolescence, as shown in the case-control study of premenopausal women published by Bernstein et al. (1994) .
Although this summary focuses on the hormonal basis for the reduction in breast cancer risk associated with physical activity, other mechanisms may be equally relevant. Both the insulin and insulin-like growth factor pathways, which have been implicated in carcinogenesis because of their roles in stimulating cell proliferation and inhibiting apoptosis (Pollak et al., 2004) , may also mediate the association between physical activity and breast cancer risk. Physical activity is associated with increases in insulin sensitivity (Rao, 2001) . Increased levels of insulin may increase breast cancer risk by downregulating SHBG, resulting in higher bioavailable estradiol (Nestler et al., 1991) , or alternatively, by downregulating insulin-like growth factor binding protein 1, resulting in increased bioavailable insulinlike growth factor-I (IGF-I; Conover et al., 1992) . High IGF-I levels have been associated with increased risk of premenopausal breast cancer (Hankinson et al., 1998) , and recent results implicate IGF-I in postmenopausal breast cancer risk (Rinaldi et al., 2006) . IGF-I exerts its effect as a mitogen in breast cell lines, and it may also be involved in promoting breast cell differentiation, breast cell transformation and suppression of apoptosis (Jones and Clemmons, 1995) . Another mechanism with less consistent or compelling evidence to support its role in mediating the breast cancer physical activity relationship is the regulation of the immune system (HoffmanGoetz et al., 1998).
Conclusion
Over the years since the early 1990s, a substantial body of evidence has accumulated regarding physical activity and breast cancer risk. Clearly, physical activity has emerged as one of the most important and consistently recognized modifiable risk factors for breast cancer. More than 50 epidemiological studies have been conducted. These show that physical activity lowers the breast cancer risk of premenopausal women as well as of postmenopausal women, women of all racial/ ethnic backgrounds and women living throughout the world. The modest variation in study results surrounding the magnitude of the impact of physical activity on breast cancer risk is likely a function of the different types of questions asked and how activity is measured. We believe that measures of lifetime activity and participation in more vigorous forms of activity are better predictors of the physical activity-breast cancer association than activity measured at a single time point or moderate intensity activities. Despite not having exact prescriptions for women as to the most beneficial type of activity, the exact duration of time needed to be active, the level of energy needed to be expended in the activity, or the ages when activity will provide the greatest benefit, it is important to communicate the message to women that exercise has numerous health benefits, including the potential to reduce breast cancer risk.
